Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Return on Sales (2018 - 2025)

AVITA Medical (RCEL) has disclosed Return on Sales for 7 consecutive years, with 0.13% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales fell 291.0% year-over-year to 0.13%, compared with a TTM value of 0.23% through Dec 2025, down 23.0%, and an annual FY2025 reading of 0.69%, down 68.0% over the prior year.
  • Return on Sales was 0.13% for Q4 2025 at AVITA Medical, up from 0.16% in the prior quarter.
  • Across five years, Return on Sales topped out at 3.09% in Q4 2022 and bottomed at 1.68% in Q1 2024.
  • Average Return on Sales over 4 years is 0.1%, with a median of 0.69% recorded in 2023.
  • Peak annual rise in Return on Sales hit 93bps in 2025, while the deepest fall reached -291bps in 2025.
  • Year by year, Return on Sales stood at 3.09% in 2022, then dropped by -14bps to 2.65% in 2023, then grew by 5bps to 2.78% in 2024, then tumbled by -105bps to 0.13% in 2025.
  • Business Quant data shows Return on Sales for RCEL at 0.13% in Q4 2025, 0.16% in Q3 2025, and 0.54% in Q2 2025.